Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S


Posted on: 21 Nov 17
Company announcement Orphazyme A/S
No. 13/2017 Ole Maaløes Vej 3
  DK-2200 Copenhagen N
   
  www.orphazyme.com
  Company Registration No. 32266355
   
   
  21 November 2017

Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 ("Orphazyme"), hereby notifies receipt of information regarding the following grants under Orphazyme's long-term incentive programme as further described in company announcement 8/2017:

1 Details of the Reporting Person / Closely Associated Person
a) Name Anders Hinsby
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Rights to acquire or subscribe for matching shares and performance shares in Orphazyme A/S

ISIN DK0060910917
b) Nature of the transaction Grant of rights (subject to certain conditions) to acquire or subscribe for matching shares and performance shares under Orphazyme A/S' long-term incentive programme  
c) Price(s) and volume(s) Price (s) Volume(s)
0 5,000 (Matching shares)
0 30,000 (Performance shares assuming full vesting)
d) Aggregated information Aggregated volume Price  
e) Date of the transaction 2017-11-21 17:00 UTC+1
f) Place of the transaction Outside a trading venue


1 Details of the Reporting Person / Closely Associated Person
a) Name Anders Vadsholt
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Rights to acquire or subscribe for matching shares and performance shares in Orphazyme A/S

ISIN DK0060910917
b) Nature of the transaction Grant of rights (subject to certain conditions) to acquire or subscribe for matching shares and performance shares under Orphazyme A/S' long-term incentive programme  
c) Price(s) and volume(s) Price (s) Volume(s)
0 4,000 (Matching shares)
0 16,000 (Performance shares assuming full vesting)
d) Aggregated information Aggregated volume Price  
e) Date of the transaction 2017-11-21 17:00 UTC+1
f) Place of the transaction Outside a trading venue


1 Details of the Reporting Person / Closely Associated Person
a) Name Thomas Kirkegaard Jensen
2 Reason for the notification
a) Position/status Chief Scientific Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Rights to acquire or subscribe for matching shares and performance shares in Orphazyme A/S

ISIN DK0060910917
b) Nature of the transaction Grant of rights (subject to certain conditions) to acquire or subscribe for matching shares and performance shares under Orphazyme A/S' long-term incentive programme  
c) Price(s) and volume(s) Price (s) Volume(s)
0 4,000 (Matching shares)
0 16,000 (Performance shares assuming full vesting)
d) Aggregated information Aggregated volume Price  
e) Date of the transaction 2017-11-21 17:00 UTC+1
f) Place of the transaction Outside a trading venue


1 Details of the Reporting Person / Closely Associated Person
a) Name Thomas Blaettler
2 Reason for the notification
a) Position/status Chief Medical Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Rights to acquire or subscribe for matching shares and performance shares in Orphazyme A/S

ISIN DK0060910917
b) Nature of the transaction Grant of rights (subject to certain conditions) to acquire or subscribe for matching shares and performance shares under Orphazyme A/S' long-term incentive programme  
c) Price(s) and volume(s) Price (s) Volume(s)
0 1,875 (Matching shares)
0 7,500 (Performance shares assuming full vesting)
d) Aggregated information Aggregated volume Price  
e) Date of the transaction 2017-11-21 17:00 UTC+1
f) Place of the transaction Outside a trading venue

For additional information, please contact

Orphazyme

Anders Vadsholt, CFO                                       +45 28 98 90 55

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/6b37567d-5422-4aa7-81d2-413e41a23b35

GlobeNewswire
globenewswire.com

Last updated on: 22/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.